High Noon-Celsius Mixup: High Noon Says Some Vodka Seltzers Were Mislabeled As Energy Drinks
The recall was announced Wednesday. (Photo by) Getty Images
The recall specifically applies to production lots of High Noon Beach Variety packs, which are 12-pack products containing 12 fluid ounce cans.
Some of the packs have cans mislabeled as the sparkling blue razz edition of Celsius' Astro Vibe energy drink, which features a silver lid instead of the drink's standard black lid.
Impacted lot codes shared by the FDA can be seen on the exterior of the High Noon 12-pack or the bottoms of the Celsius cans.
No illnesses or adverse events have been reported for the recall as of Wednesday, though High Noon has advised those with the impacted Celsius lot codes to not consume the vodka seltzer alcohol in the cans.
People who purchased impacted 12-packs can contact High Noon consumer relations to receive information on refunds.
Get Forbes Breaking News Text Alerts : We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text 'Alerts' to (201) 335-0739 or sign up here .
The affected 12-packs were sent to retailers in Florida, Michigan, New York, Ohio, Oklahoma, South Carolina, Virginia and Wisconsin, according to High Noon. How Did The Celsius Cans End Up In High Noon Packs?
High Noon said in a statement published by the FDA the mixup occurred because a packaging supplier who works with High Noon and Celsius mistakenly shipped empty energy drink cans to High Noon.
High Noon was released in 2019 and has since become the top-selling spirit brand by volume in the U.S., offering vodka and tequila hard seltzers and vodka iced teas. The brand sold an estimated 21.4 million cases in 2023, according to The Spirits Business, which cited data from Shanken's Impact Databank of the spirits market. Celsius is owned by Celsius Holdings but has a major shareholder in PepsiCo, which has invested $550 million into the energy drink brand. The company reported $306.5 million in revenue from the North American market, a 10% drop from the same quarter a year ago. Further Reading
High Noon Announces Recall of its Vodka Seltzer Beach Pack (12 Pack) Due to Inclusion of Celsius Astro Vibe Energy Drink Cans that were Inadvertently Filled with Vodka Seltzer (FDA)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Alzheimer's DMT Market to Grow at 67.8% CAGR Through 2030
"Driven by urgent unmet needs and scientific advances, the Alzheimer's Disease DMT market is poised for rapid growth as pharmaceutical companies shift their focus to multi-target therapies that address the complex pathology of the disease." BOSTON, Aug. 13, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "Disease-Modifying Therapies for Alzheimer's Disease: Global Markets" is projected to reach $13.1 billion by the end of 2030, growing at a CAGR of 67.8% during the forecast period of 2025-2030. The Alzheimer's disease (AD) disease-modifying therapies (DMTs) market is in its early stages, with lecanemab being the first fully approved DMT by the U.S. FDA in July 2023. Several other DMTs in late-stage trials could significantly expand the market if approved. BCC Research forecasts future revenues based on current products and potential candidates. The report analyzes the market by target type (anti-amyloid and emerging targets), drug (Leqembi, Kisunla, and others), molecule type (large and small), and region (Asia-Pacific, North America, Europe, South America, and the Middle East and Africa). This report is particularly relevant today because the Alzheimer's disease (AD) DMT market is in its early stage of development, with several therapies currently in late-stage clinical trials. If these therapies are approved, they could significantly expand the market and reshape treatment options. In this context, studying the AD DMTs market is both timely and crucial for pharmaceutical companies and industry stakeholders. The report offers essential market and business insights, helping participants in the AD drugs industry make informed decisions and prepare for upcoming opportunities. The factors driving the market's growth include: High Unmet Need in AD Treatment: Alzheimer's disease currently lacks effective long-term treatments, with existing options only offering temporary symptom relief. This creates a strong demand for therapies that can slow or halt disease progression, encouraging investment, innovation, and regulatory support for disease-modifying therapies. Use of Biomarkers to Accelerate Approvals of AD DMTs: Biomarkers like amyloid-beta and tau proteins help detect Alzheimer's early and track its progression. Their use in clinical trials allows faster and more precise evaluation of new therapies, enabling quicker regulatory approvals and more targeted treatment development. Request a sample copy of the global and regional markets for disease-modifying therapies for Alzheimer's disease report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $235.8 million Market size forecast $13.1 billion Growth rate CAGR of 67.8% for the forecast period of 2025-2030 Segments covered Target Type, Drug Type, Drug Molecule Type, and Region Regions covered North America, Europe, Asia-Pacific, South America, Middle East and Africa Market drivers • High unmet need in AD treatment. • Use of biomarkers to accelerate AD DMTs approval. Interesting facts: As of May 2025, over half of the AD therapeutic candidates in phase 3 trials are disease modifying small molecules ( There are very few DMTs targeting the moderate to advanced stages of AD. Emerging startups: AgeneBio Inc.: The company is investigating AGB101 (levetiracetam) in phase 2 and 3 clinical trials for the treatment of hippocampal overactivity and to assess its ability to control progression to Alzheimer's dementia. Currently, no treatments have shown these benefits. TauRx Pharmaceuticals: TauRx's research centers on tau aggregation inhibitors (TAIs), which aim to prevent or reverse the formation of tau protein tangles in the brain. TRx0237 is a late-stage AD therapeutic candidate. It is an oral tau aggregation inhibitor designed for early intervention to modify the underlying disease process and slow the progression of AD. The report addresses the following questions: What are the projected size and growth rate of the Alzheimer's disease-modifying therapies market?- The global Alzheimer's DMT market was estimated at $235.8 million in 2024. The market is projected to reach $13.1 billion in by the end of 2030, growing at a CAGR of 67.8% during the forecast period. Which market segments are covered in the report?- Target type, drug, molecule type, and region. Which target type will be dominant through 2030?- By target type, the anti-amyloid segment is expected to be the largest market by the end of 2030. Which molecule type market is growing the fastest?- The large molecule segment is the fastest growing market. What are the key challenges in of the market?- Modest clinical benefits, significant risk of side effects, and the high cost of approved DMTs remain challenges to the widespread adoption of these drugs. Market leaders include: ALZHEON INC. ANAVEX LIFE SCIENCES CORP. ANNOVIS BIO INC. BIOGEN BIOVIE INC. EISAI CO. LTD. JOHNSON & JOHNSON LILLY NOVO NORDISK A/S TAURX PHARMACEUTICALS LTD. Related reports: Neurology Market: A BCC Research Overview: This report offers a detailed analysis of the global neurology therapeutics market, segmented by conditions such as Parkinson's, Alzheimer's, epilepsy, autism, psychotic disorders, multiple sclerosis, and brain tumors. It explores drug classes, market dynamics, pipeline developments, competitive landscape, and regional trends across North America, Europe, Asia-Pacific, and the Rest of the World, providing insights into current and future market potential. Alzheimer's Disease Therapeutics and Diagnostics: Global Markets: This report provides an overview of the global Alzheimer's disease diagnostics and therapeutics market, focusing exclusively on biomarker tests for diagnostics and approved pharmacological treatments for therapeutics. It excludes cognitive tests, neuroimaging, procedural interventions, and off-label drug use. The market is segmented by test type, drug class, disease stage, and region, and includes analysis of clinical trials, innovations, and emerging trends. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Sign in to access your portfolio
Yahoo
6 hours ago
- Yahoo
Flesh-eating bacteria have caused several deaths in Florida and Louisiana this summer. How to reduce your risk of Vibrio vulnificus infection before swimming in the ocean.
Infections are rare, but a person can get sick by swimming in the ocean with an open wound or by eating contaminated raw shellfish. Health officials in several states are alerting residents about a flesh-eating bacteria that thrives in warm coastal waters. Approximately 60 cases of Vibrio vulnificus have been confirmed in 11 states, according to Today. The highest numbers have been in Louisiana (17 cases, including 4 deaths) and Florida (16 cases, including 5 deaths). North Carolina has also seen 7 cases, Yahoo News confirmed with the state's Department of Health and Human Services via email. Vibrio vulnificus cases are considered rare, with between 150 and 200 infections reported in the U.S. each year, according to the Cleveland Clinic. However, many people with an infection can become seriously ill, requiring intensive care or limb amputation. 'About 1 in 5 people with this infection die, sometimes within a day or two of becoming ill,' according to the Centers for Disease Control and Prevention. Does this mean you should avoid the ocean altogether? Here's what to know and what safety measures to keep in mind: What is Vibrio vulnificus? Vibrio are a type of bacteria that thrive in warm coastal waters during the summer months from May to October. This includes salt water and brackish water, which is a mixture of salt and freshwater often found where rivers meet the ocean. The bacteria are found particularly along the Gulf Coast states like Florida, Louisiana, Texas, Alabama and Mississippi. There are different kinds of Vibrio that can lead to various infections. Vibrio vulnificus can be particularly dangerous because it can cause severe and life-threatening infections. This specific type of bacteria is known as 'flesh-eating' because it can destroy muscle tissue and skin. 'Many people with [Vibrio] vulnificus wound infection require intensive care or surgical tissue removal,' the CDC says. How do people get infected? There are two ways that people can get infected: When a person's open wound is exposed to ocean water or seafood contaminated with Vibrio bacteria. A small cut, scrape or wound from a recent surgery, piercing or tattoo can allow bacteria in. This can happen when a person goes swimming or fishing or prepares raw seafood. When someone eats raw or undercooked seafood or ingests contaminated water while swimming. Oysters, in particular, can concentrate the Vibrio bacteria inside them. What are the symptoms of a Vibrio infection? These are the common signs and symptoms of a Vibrio infection, according to the CDC: Watery diarrhea Stomach cramps Nausea and vomiting Fever/chills Signs of a Vibrio bloodstream infection: Fever/chills Dangerously low blood pressure Blistering skin lesions Signs of a Vibrio wound infection: Fever Pain, redness, swelling, warmth at the wound site Redness Pain Swelling Warmth Discoloration (turning a color other than normal) Discharge (leaking fluids) The Cleveland Clinic and the CDC advise people to go to the emergency room immediately if there are signs of a suspected Vibrio vulnificus infection. Are some people more at risk of an infection? Anyone can become infected with the bacteria through a wound. People with underlying health conditions like liver disease, diabetes and immunocompromising conditions are at higher risk for wound infection, according to the CDC. How can people stay safe? Florida's Health Department and the CDC provide some tips to prevent Vibrio vulnificus infections: Don't eat raw oysters and other raw shellfish. Instead, cook them thoroughly. Avoid cross contamination with raw seafood and other cooked food or shellfish. If you have an open wound or broken skin, avoid warm salt or brackish water, if possible. Cover your wound with a waterproof bandage if it could come into contact with coastal water, raw seafood or its drippings or juices. Wear protective gloves or clothing when handling raw shellfish. Be vigilant after coastal floods, hurricanes and storm surges. Coastal waters forced into inland areas increase the risk for Vibrio wound infections, particularly for people who are older or who have underlying health conditions.
Business Upturn
7 hours ago
- Business Upturn
MobilityMD Introduces Clean, Ingredient-First Approach to Joint Comfort and Flexibility in 2025
Salt Lake City, Aug. 12, 2025 (GLOBE NEWSWIRE) — Disclaimer: This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). MobilityMD is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. Joint comfort and flexibility are vital for maintaining an active, independent lifestyle — whether it's enjoying daily walks, engaging in sports, or simply moving through the day without stiffness. The conversation around joint health is shifting toward preventative, natural options that align with long-term wellness goals in 2025. MobilityMD has emerged as part of this dialogue, offering a joint support formula built on a foundation of purity, ingredient transparency, and thoughtful formulation. While it avoids overpromising results, the supplement positions itself within the growing category of wellness products designed to complement healthy movement and an active lifestyle. Discover how MobilityMD's carefully selected ingredients are shaping the conversation around joint wellness in 2025. SECTION 1: WHY INTEREST IN 'THE SECRET, PURE INGREDIENT TO SUPPORT HEALTHY JOINTS' IS SURGING IN 2025 Joint health has become a central focus for people of all ages in 2025 — from active adults looking to preserve mobility to those seeking extra support for daily comfort. This growing attention is reflected in online search trends, with Google reporting increases in queries like 'natural joint support,' 'supplements for flexibility,' and 'best ingredients for mobility.' The public is no longer just looking for quick fixes; instead, there is heightened curiosity around long-term strategies that integrate into a balanced, healthy lifestyle. Part of this shift comes from the broader wellness movement, where consumers prioritize transparency, clean sourcing, and minimal additives in the products they choose. Social media platforms, wellness podcasts, and fitness forums are filled with discussions comparing ingredient profiles, sharing personal experiences, and evaluating which formulas fit into individual health routines. MobilityMD has entered this conversation not by making sweeping claims, but by highlighting its focus on purity and thoughtful formulation. This aligns with the expectations of today's wellness-conscious consumers, who often seek products designed to complement an active lifestyle without relying on unnecessary fillers or synthetic additives. SECTION 2: MOBILITYMD'S INGREDIENT-FIRST RESPONSE TO THESE TRENDS MobilityMD was developed with a clear focus on sourcing and formulation choices that align with the modern consumer's expectations for clean, purposeful supplementation. Rather than relying on heavily processed or synthetic compounds, the formula incorporates naturally derived ingredients that have been historically discussed for their association with mobility and joint comfort. Each component is chosen with the intent to complement an active lifestyle while avoiding unnecessary additives that do not contribute to the product's purpose. The ingredient selection process emphasizes purity and transparency. This includes providing clear information about sourcing, composition, and function so that consumers can make informed choices about what they put into their bodies. The formulation also considers how different ingredients work together, aiming for a balanced profile that fits into a variety of health routines — from daily wellness habits to more targeted mobility-focused regimens. Importantly, MobilityMD avoids making direct medical claims. Instead, it positions itself as part of a broader wellness strategy, one that supports consumers in pursuing movement-friendly lifestyles while staying mindful of ingredient integrity. Discover how MobilityMD's ingredient transparency reflects the growing demand for cleaner, more purposeful joint support supplements. SECTION 3: INGREDIENT SPOTLIGHT – WHAT'S INSIDE THE FORMULA The foundation of MobilityMD lies in a carefully curated selection of naturally derived ingredients, each frequently discussed in wellness circles for their historical associations with joint comfort and mobility. While the product avoids making direct health claims, it draws on a blend that reflects both tradition and modern supplement formulation trends. Key components often include botanical extracts that have been explored for their potential to support overall wellness, minerals that play a role in maintaining balanced body functions, and naturally occurring compounds that have been studied for their relevance to healthy aging. Each ingredient is chosen with attention to purity, potency, and its ability to integrate seamlessly into a daily health regimen. MobilityMD also emphasizes the importance of what's left out of the formula. There are no unnecessary fillers, artificial colors, or synthetic preservatives — a choice that resonates with consumers who are mindful of every element they consume. This focus on clean composition positions the supplement within the growing category of wellness products designed for individuals who prioritize ingredient integrity as much as potential functional benefits. SECTION 4: WHAT REDDIT, PODCASTS & TIKTOK CREATORS ARE SAYING Conversations about joint health supplements have expanded well beyond traditional advertising channels in 2025. On Reddit, wellness and fitness communities are filled with discussions about ingredient quality, transparency, and the importance of long-term consistency in supplementation. Users frequently share their experiences with products that align with clean-label trends, and MobilityMD has been mentioned in threads that focus on naturally derived joint support options. Podcasts in the health and wellness space often highlight how consumers are becoming more discerning about supplement choices. Guests on these shows frequently emphasize reading ingredient labels, understanding sourcing, and looking for products that complement an active lifestyle. MobilityMD's ingredient-focused approach aligns with these ongoing discussions, making it a relevant part of broader wellness dialogues. On TikTok, creators in the fitness, yoga, and lifestyle categories are producing short-form content around joint-friendly routines, mobility exercises, and supplement habits that fit into a balanced regimen. While these creators don't make specific claims about results, they often showcase how clean-label supplements can be integrated alongside movement practices to support overall wellness. Learn why MobilityMD is appearing in more conversations about clean, transparent joint support in 2025. SECTION 5: WHO MIGHT BE DRAWN TO THIS TYPE OF SUPPLEMENTATION IN 2025 MobilityMD appeals to a wide range of individuals who prioritize maintaining joint comfort and flexibility as part of their overall wellness goals. Active adults, including those who enjoy walking, hiking, yoga, or recreational sports, may be drawn to the idea of a supplement that aligns with their lifestyle without unnecessary additives. Professionals who spend long hours sitting or standing may also find the clean-label approach appealing, as they look for ways to support movement and ease in daily routines. Similarly, older adults seeking to remain active and independent often look for supplements with a transparent ingredient list that avoids synthetic fillers or artificial preservatives. The eco-conscious and health-conscious crowd is another natural audience for MobilityMD. For these individuals, supplement choice is about more than potential functional benefits — it's about knowing that the formula is built on pure, purposeful components. This aligns with the broader wellness movement of 2025, where consumers increasingly value products that support their personal health goals while also reflecting their ethical and environmental values. SECTION 6: EMERGING WELLNESS & PERFORMANCE INNOVATION – 2025 MARKET REFLECTIONS The wellness and supplement market in 2025 reflects a distinct shift toward ingredient transparency, clean-label formulations, and products that fit seamlessly into long-term health routines. Consumers are increasingly skeptical of overpromising claims and are instead prioritizing supplements that are clear about their composition and intended role in a balanced lifestyle. This has created a strong market for products like MobilityMD, which position themselves as part of a broader wellness toolkit rather than a one-step solution. This trend is driven in part by the rise of self-education in health and nutrition. With more information available online than ever before, people are researching ingredients, comparing labels, and making purchasing decisions based on both scientific discussion and personal values. Social media platforms, wellness blogs, and community forums all contribute to this heightened awareness, creating a consumer base that demands higher standards from supplement brands. Within this environment, joint health remains a high-priority category. As active lifestyles, desk-based work, and healthy aging all intersect, the demand for products that align with everyday mobility needs continues to grow. MobilityMD's focus on purity and purposeful formulation allows it to stand out in a competitive market where consumers are looking for supplements that are as trustworthy as they are functional. Discover why MobilityMD is part of the new wave of clean, ingredient-first wellness products in 2025. SECTION 7: THE PUBLIC DEBATE AROUND JOINT HEALTH SUPPLEMENTS – SIGNALS, SKEPTICISM, AND SATURATION The conversation around joint health supplements in 2025 is both active and divided. Supporters often point to the importance of staying proactive with mobility support, highlighting the role of clean, naturally derived ingredients in long-term wellness routines. They value brands that offer transparency and avoid unnecessary additives, seeing these products as part of a broader strategy to maintain active, comfortable movement. Skeptics, however, question whether supplements are necessary for everyone and emphasize the need for realistic expectations. They often stress that lifestyle habits — such as regular movement, balanced nutrition, and proper hydration — form the foundation of joint health, with supplementation serving as a complement rather than a replacement. Neutral observers see the market as one experiencing rapid expansion, but also increased scrutiny. With many brands competing for attention, consumers are becoming more selective, favoring companies that provide clear ingredient information and maintain a consistent focus on product integrity. For products like MobilityMD, standing out means continuing to align with the values of informed, wellness-conscious buyers while avoiding overreaching claims. SECTION 8: ABOUT MOBILITYMD MobilityMD was created with a clear mission — to offer a joint support supplement that prioritizes purity, ingredient transparency, and alignment with modern wellness values. The brand focuses on sourcing naturally derived components that have been historically discussed in wellness communities for their association with mobility and comfort, while avoiding unnecessary additives or synthetic fillers. Every aspect of the product, from formulation to packaging, reflects a commitment to integrity. MobilityMD positions itself not as a quick-fix solution, but as part of a balanced lifestyle that may include movement practices, mindful nutrition, and regular self-care. By maintaining a clear, educational approach to its ingredients and purpose, the brand builds trust with consumers seeking a supplement that fits seamlessly into their long-term wellness routines. In a supplement landscape crowded with exaggerated promises, MobilityMD stands out for its straightforward, ingredient-first philosophy — offering a choice for those who value both product quality and transparency. See how MobilityMD's ingredient-focused approach is resonating with today's wellness-conscious consumers. SECTION 9: CONTACT MobilityMD – Clean, Ingredient-First Joint Support – Clean, Ingredient-First Joint Support Email: [email protected] Disclaimer: This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). MobilityMD is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
